Frontiers in molecular radiation biology/oncology

Radiotherapy and Oncology

Volumn 101, Issue 1, 2011, Pages 1-6

  Rodemann, Hans Peter ^a   Wouters, Bradly G ^b,c  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b PRINCESS MARGARET HOSPITAL   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; TUMOR MARKER;

CONFERENCE PAPER; DNA DAMAGE; DNA REPAIR; DRUG TARGETING; EXCISION REPAIR; HOMOLOGOUS RECOMBINATION; HUMAN; MICROENVIRONMENT; ONCOLOGY; PRIORITY JOURNAL; RADIOBIOLOGY; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 80655123141     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2011.09.020     Document Type: Conference Paper

References (178)

1. C.N. Andreassen, and J. Alsner Genetic variants and normal tissue toxicity after radiotherapy: a systematic review Radiother Oncol 92 2009 299 309
2. G. Iliakis Backup pathways of NHEJ in cells of higher eukaryotes: cell cycle dependence Radiother Oncol 92 2009 310 315
3. R.E. Meyn, A. Munshi, J.V. Haymach, L. Milas, and K.K. Ang Receptor signaling as a regulatory mechanism of DNA repair Radiother Oncol 92 2009 316 322
4. D.A. Gewirtz, M.L. Hilliker, and E.N. Wilson Promotion of autophagy as a mechanism for radiation sensitization of breast tumor cells Radiother Oncol 92 2009 323 328
5. O. Feron Pyruvate into lactate and back: from the Warburg effect to symbiotic energy fuel exchange in cancer cells Radiother Oncol 92 2009 329 333
6. U. Florczak, M. Toulany, R. Kehlbach, and H. Peter Rodemann 2-Methoxyestradiol-induced radiosensitization is independent of SOD but depends on inhibition of Akt and DNA-PKcs activities Radiother Oncol 92 2009 334 338
7. J.A. Bonner, H.Q. Trummell, C.D. Willey, B.A. Plants, and K.P. Raisch Inhibition of STAT-3 results in radiosensitization of human squamous cell carcinoma Radiother Oncol 92 2009 339 344
8. L. Xing, X. Sun, and X. Deng Expression of the bifunctional suicide gene CDUPRT increases radiosensitization and bystander effect of 5-FC in prostate cancer cells Radiother Oncol 92 2009 345 352
9. C. Dittfeld, A. Dietrich, and S. Peickert CD133 expression is not selective for tumor-initiating or radioresistant cell populations in the CRC cell lines HCT-116 Radiother Oncol 92 2009 353 361
10. S. Hehlgans, I. Eke, K. Storch, M. Haase, G.B. Baretton, and N. Cordes Caveolin-1 mediated radioresistance of 3D grown pancreatic cancer cells Radiother Oncol 92 2009 362 370
11. S. Hehlgans, I. Lange, I. Eke, and N. Cordes 3D cell cultures of human head and neck squamous cell carcinoma cells are radiosensitized by the focal adhesion kinase inhibitor TAE226 Radiother Oncol 92 2009 371 378
12. K. Dittmann, C. Mayer, R. Kehlbach, M.C. Rothmund, and H. Peter Rodemann Radiation-induced lipid peroxidation activates src kinase and triggers nuclear EGFR transport Radiother Oncol 92 2009 379 382
13. O. Riesterer, K.A. Mason, and U. Raju Enhanced response to C225 of A431 tumor xenografts growing in irradiated tumor bed Radiother Oncol 92 2009 383 387
14. N. Zhang, K. Erjala, and J. Kulmala Concurrent cetuximab, cisplatin, and radiation for squamous cell carcinoma of the head and neck in vitro Radiother Oncol 92 2009 388 392
15. B. Jutten, L. Dubois, and Y. Li Binding of cetuximab to the EGFRvIII deletion mutant and its biological consequences in malignant glioma cells Radiother Oncol 92 2009 393 398
16. J. Theys, B. Jutten, and L. Dubois The deletion mutant EGFRvIII significantly contributes to stress resistance typical for the tumour microenvironment Radiother Oncol 92 2009 399 404
17. D. Zips, K. Le, and A. Yaromina Triple angiokinase inhibition, tumour hypoxia and radiation response of FaDu human squamous cell carcinomas Radiother Oncol 92 2009 405 410
18. K.M. Rouschop, C.H. Ramaekers, and M.B. Schaaf Autophagy is required during cycling hypoxia to lower production of reactive oxygen species Radiother Oncol 92 2009 411 416
19. M.H. Starmans, D. Zips, B.G. Wouters, M. Baumann, and P. Lambin The use of a comprehensive tumour xenograft dataset to validate gene signatures relevant for radiation response Radiother Oncol 92 2009 417 422
20. L. Dubois, N.G. Lieuwes, and A. Maresca Imaging of CA IX with fluorescent labelled sulfonamides distinguishes hypoxic and (re)-oxygenated cells in a xenograft tumour model Radiother Oncol 92 2009 423 428
21. M. Busk, M.R. Horsman, and S. Jakobsen Can hypoxia-PET map hypoxic cell density heterogeneity accurately in an animal tumor model at a clinically obtainable image contrast? Radiother Oncol 92 2009 429 436
22. T. van den Beucken, C.H. Ramaekers, K. Rouschop, M. Koritzinsky, and B.G. Wouters Deficient carbonic anhydrase 9 expression in UPR-impaired cells is associated with reduced survival in an acidic microenvironment Radiother Oncol 92 2009 437 442
23. B.S. Sorensen, M.R. Horsman, H. Vorum, B. Honore, J. Overgaard, and J. Alsner Proteins upregulated by mild and severe hypoxia in squamous cell carcinomas in vitro identified by proteomics Radiother Oncol 92 2009 443 449
24. H. Mujcic, T. Rzymski, and K.M. Rouschop Hypoxic activation of the unfolded protein response (UPR) induces expression of the metastasis-associated gene LAMP3 Radiother Oncol 92 2009 450 459
25. A. Yaromina, A. Eckardt, and D. Zips Core needle biopsies for determination of the microenvironment in individual tumours for longitudinal radiobiological studies Radiother Oncol 92 2009 460 465
26. J. Feng, M. van der Zwaag, M.A. Stokman, R. van Os, and R.P. Coppes Isolation and characterization of human salivary gland cells for stem cell transplantation to reduce radiation-induced hyposalivation Radiother Oncol 92 2009 466 471
27. Z. Jing, L. Gong, and C.Y. Xie Reverse resistance to radiation in KYSE-150R esophageal carcinoma cell after epidermal growth factor receptor signal pathway inhibition by cetuximab Radiother Oncol 93 2009 468 473
28. J. Haagen, H. Krohn, S. Rollig, M. Schmidt, K. Wolfram, and W. Dorr Effect of selective inhibitors of inflammation on oral mucositis: preclinical studies Radiother Oncol 92 2009 472 476
29. N.S. Russell, S. Hoving, and S. Heeneman Novel insights into pathological changes in muscular arteries of radiotherapy patients Radiother Oncol 92 2009 477 483
30. M. Scharpfenecker, B. Floot, N.S. Russell, P. Ten Dijke, and F.A. Stewart Endoglin haploinsufficiency reduces radiation-induced fibrosis and telangiectasia formation in mouse kidneys Radiother Oncol 92 2009 484 491
31. C. Ostrau, J. Hulsenbeck, and M. Herzog Lovastatin attenuates ionizing radiation-induced normal tissue damage in vivo Radiother Oncol 92 2009 492 499
32. A.E. Para, A. Bezjak, I.W. Yeung, J. Van Dyk, and R.P. Hill Effects of genistein following fractionated lung irradiation in mice Radiother Oncol 92 2009 500 510
33. P.L. Olive, C.A. Banuelos, R.E. Durand, J.Y. Kim, and C. Aquino-Parsons Endogenous and radiation-induced expression of gammaH2AX in biopsies from patients treated for carcinoma of the uterine cervix Radiother Oncol 94 2010 82 89
34. I. Turesson, J. Nyman, and F. Qvarnstrom A low-dose hypersensitive keratinocyte loss in response to fractionated radiotherapy is associated with growth arrest and apoptosis Radiother Oncol 94 2010 90 101
35. M. Toulany, R. Kehlbach, H.P. Rodemann, and H. Mozdarani Radiocontrast media affect radiation-induced DNA damage repair in vitro and in vivo by affecting Akt signalling Radiother Oncol 94 2010 110 116
36. P. Porcedda, V. Turinetto, and L. Orlando Two-tier analysis of histone H2AX phosphorylation allows the identification of Ataxia Telangiectasia heterozygotes Radiother Oncol 92 2009 133 137
37. D. Ziogas, T. Liakakos, E. Lykoudis, E. Fatourou, and D.H. Roukos Exploring the role of BRCA1, BRCA2 and RAD51 as biomarkers for breast cancer Radiother Oncol 90 2009 161 162
38. U. Kasten-Pisula, A. Menegakis, and I. Brammer The extreme radiosensitivity of the squamous cell carcinoma SKX is due to a defect in double-strand break repair Radiother Oncol 90 2009 257 264
39. M. Takagi, K. Sakata, and M. Someya Gimeracil sensitizes cells to radiation via inhibition of homologous recombination Radiother Oncol 96 2010 259 266
40. K. Koch, A. Wrona, E. Dikomey, and K. Borgmann Impact of homologous recombination on individual cellular radiosensitivity Radiother Oncol 90 2009 265 272
41. A.C. Begg, F.A. Stewart, and C. Vens Strategies to improve radiotherapy with targeted drugs Nat Rev Cancer 11 2011 239 253
42. I. Vitale, L. Galluzzi, M. Castedo, and G. Kroemer Mitotic catastrophe: a mechanism for avoiding genomic instability Nat Rev Mol Cell Biol 12 2011 385 392
43. S. Neijenhuis, A.C. Begg, and C. Vens Radiosensitization by a dominant negative to DNA polymerase beta is DNA polymerase beta-independent and XRCC1-dependent Radiother Oncol 76 2005 123 128 (Pubitemid 41725437)
44. S.J. Veuger, N.J. Curtin, C.J. Richardson, G.C. Smith, and B.W. Durkacz Radiosensitization and DNA repair inhibition by the combined use of novel inhibitors of DNA-dependent protein kinase and poly(ADP-ribose) polymerase-1 Cancer Res 63 2003 6008 6015 (Pubitemid 37187504)
45. I. Hickson, Y. Zhao, and C.J. Richardson Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATM Cancer Res 64 2004 9152 9159 (Pubitemid 39665530)
46. M.D. Rainey, M.E. Charlton, R.V. Stanton, and M.B. Kastan Transient inhibition of ATM kinase is sufficient to enhance cellular sensitivity to ionizing radiation Cancer Res 68 2008 7466 7474
47. L. Zhang, M. Yang, and N. Bi Association of TGF-beta1 and XPD polymorphisms with severe acute radiation-induced esophageal toxicity in locally advanced lung cancer patients treated with radiotherapy Radiother Oncol 97 2010 19 25
48. O. Zschenker, A. Raabe, and I.K. Boeckelmann Association of single nucleotide polymorphisms in ATM, GSTP1, SOD2, TGFB1, XPD and XRCC1 with clinical and cellular radiosensitivity Radiother Oncol 97 2010 26 32
49. D. De Ruysscher, D. Severin, and E. Barnes First report on the patient database for the identification of the genetic pathways involved in patients over-reacting to radiotherapy: GENEPI-II Radiother Oncol 97 2010 36 39
50. K. Dittmann, C. Mayer, B. Fehrenbacher, M. Schaller, R. Kehlbach, and H.P. Rodemann Nuclear epidermal growth factor receptor modulates cellular radio-sensitivity by regulation of chromatin access Radiother Oncol 99 2011 317 322
51. A.J. Chalmers, M. Lakshman, N. Chan, and R.G. Bristow Poly(ADP-ribose) polymerase inhibition as a model for synthetic lethality in developing radiation oncology targets Semin Radiat Oncol 20 2010 274 281
52. S.K. Liu, C. Coackley, M. Krause, F. Jalali, N. Chan, and R.G. Bristow A novel poly(ADP-ribose) polymerase inhibitor, ABT-888, radiosensitizes malignant human cell lines under hypoxia Radiother Oncol 88 2008 258 268
53. Y. Drew, E.A. Mulligan, and W.T. Vong Therapeutic potential of poly(ADP-ribose) polymerase inhibitor AG014699 in human cancers with mutated or methylated BRCA1 or BRCA2 J Natl Cancer Inst 103 2011 334 346
54. Y. Drew, and R. Plummer PARP inhibitors in cancer therapy: two modes of attack on the cancer cell widening the clinical applications Drug Resist Updat 12 2009 153 156
55. F.A. Dungey, K.W. Caldecott, and A.J. Chalmers Enhanced radiosensitization of human glioma cells by combining inhibition of poly(ADP-ribose) polymerase with inhibition of heat shock protein 90 Mol Cancer Ther 8 2009 2243 2254
56. F.A. Dungey, D.A. Loser, and A.J. Chalmers Replication-dependent radiosensitization of human glioma cells by inhibition of poly(ADP-Ribose) polymerase: mechanisms and therapeutic potential Int J Radiat Oncol Biol Phys 72 2008 1188 1197
57. M. Verheij, C. Vens, and B. van Triest Novel therapeutics in combination with radiotherapy to improve cancer treatment: rationale, mechanisms of action and clinical perspective Drug Resist Updat 13 2010 29 43
58. N. Srivastava, S. Gochhait, P. de Boer, and R.N. Bamezai Role of H2AX in DNA damage response and human cancers Mutat Res 681 2009 180 188
59. K.S. Cho, L.I. Elizondo, and C.F. Boerkoel Advances in chromatin remodeling and human disease Curr Opin Genet Dev 14 2004 308 315 (Pubitemid 38686937)
60. A.A. Goodarzi, A.T. Noon, and P.A. Jeggo The impact of heterochromatin on DSB repair Biochem Soc Trans 37 2009 569 576
61. A.A. Goodarzi, P. Jeggo, and M. Lobrich The influence of heterochromatin on DNA double strand break repair: getting the strong, silent type to relax DNA Repair (Amst) 9 2010 1273 1282
62. C.M. Doll, M. Prystajecky, and M. Eliasziw Low ERCC1 mRNA and protein expression are associated with worse survival in cervical cancer patients treated with radiation alone Radiother Oncol 97 2010 352 359
63. H.P. Rodemann, K. Dittmann, and M. Toulany Radiation-induced EGFR-signaling and control of DNA-damage repair Int J Radiat Biol 83 2007 781 791 (Pubitemid 350219102)
64. M. Toulany, and H.P. Rodemann Membrane receptor signaling and control of DNA repair after exposure to ionizing radiation. Nuklearmedizin Nucl Med 49 2010 S26 S30
65. M.L. Chua, N. Somaiah, and R. A'Hern Residual DNA and chromosomal damage in ex vivo irradiated blood lymphocytes correlated with late normal tissue response to breast radiotherapy Radiother Oncol 99 2011 362 366
66. J. Gaedcke, M. Grade, and K. Jung KRAS and BRAF mutations in patients with rectal cancer treated with preoperative chemoradiotherapy Radiother Oncol 94 2010 76 81
67. I. Skvortsova, S. Skvortsov, and U. Raju Epithelial-to-mesenchymal transition and c-myc expression are the determinants of cetuximab-induced enhancement of squamous cell carcinoma radioresponse Radiother Oncol 96 2010 108 115
68. Y. Belkacemi, and J. Gligorov Concurrent trastuzumab - Internal mammary irradiation for HER2 positive breast cancer: "It hurts to be on the cutting edge" Radiother Oncol 94 2010 119 120 author reply 20-1
69. I.A. Kim, M. No, and J.M. Lee Epigenetic modulation of radiation response in human cancer cells with activated EGFR or HER-2 signaling: potential role of histone deacetylase 6 Radiother Oncol 92 2009 125 132
70. M.C. Merlano, and E.G. Russi Epidermal growth factor receptor-inhibitors and radiotherapy-induced cutaneous adverse effects: "Koebner- Phenomenon" or radio-dermatitis? Radiother Oncol 92 2009 142 143
71. Z. Khan, N. Khan, R.P. Tiwari, I.K. Patro, G.B. Prasad, and P.S. Bisen Down-regulation of surviving by oxaliplatin diminishes radioresistance of head and neck squamous carcinoma cells Radiother Oncol 96 2010 267 273
72. J.G. Eriksen, and M. Overgaard Late onset of skin toxicity induced by EGFr-inhibitors Radiother Oncol 90 2009 280 281
73. I. Skvortsova Oxidative damage and cutaneous reactions during radiotherapy in combination with cetuximab Radiother Oncol 90 2009 281 282
74. C. Li, M. Iida, E.F. Dunn, and D.L. Wheeler Dasatinib blocks cetuximab- and radiation-induced nuclear translocation of the epidermal growth factor receptor in head and neck squamous cell carcinoma Radiother Oncol 97 2010 330 337
75. M. Toulany, M. Minjgee, R. Kehlbach, J. Chen, M. Baumann, and H.P. Rodemann ErbB2 expression through heterodimerization with erbB1 is necessary for ionizing radiation- but not EGF-induced activation of Akt survival pathway Radiother Oncol 97 2010 338 345
76. R. Handrick, U. Ganswindt, and H. Faltin Combined action of celecoxib and ionizing radiation in prostate cancer cells is independent of pro-apoptotic Bax Radiother Oncol 90 2009 413 421
77. M.J. Sambade, J.T. Camp, R.J. Kimple, C.I. Sartor, and J.M. Shields Mechanism of lapatinib-mediated radiosensitization of breast cancer cells is primarily by inhibition of the Raf > MEK > ERK mitogen-activated protein kinase cascade and radiosensitization of lapatinib-resistant cells restored by direct inhibition of MEK Radiother Oncol 93 2009 639 644
78. J.A. Bonner, E.S. Yang, H.Q. Trummell, S. Nowsheen, C.D. Willey, and K.P. Raisch Inhibition of STAT-3 results in greater cetuximab sensitivity in head and neck squamous cell carcinoma Radiother Oncol 99 2011 339 343
79. K. Gurtner, Y. Deuse, and R. Butof Diverse effects of combined radiotherapy and EGFR inhibition with antibodies or TK inhibitors on local tumour control and correlation with EGFR gene expression Radiother Oncol 99 2011 323 330
80. S. Nowsheen, J.A. Bonner, and E.S. Yang The poly(ADP-Ribose) polymerase inhibitor ABT-888 reduces radiation-induced nuclear EGFR and augments head and neck tumor response to radiotherapy Radiother Oncol 99 2011 331 338
81. H.P. Rodemann, and M.A. Blaese Responses of normal cells to ionizing radiation Semin Radiat Oncol 17 2007 81 88 (Pubitemid 46467380)
82. P.M. Harari, G.W. Allen, and J.A. Bonner Biology of interactions: antiepidermal growth factor receptor agents J Clin Oncol 25 2007 4057 4065 (Pubitemid 47492950)
83. A. Santiago, W. Eicheler, and J. Bussink Effect of cetuximab and fractionated irradiation on tumour micro-environment Radiother Oncol J Eur Soc Ther Radiol Oncol 97 2010 322 329
84. B. Mukherjee, H. Choy, C. Nirodi, and S. Burma Targeting nonhomologous end-joining through epidermal growth factor receptor inhibition: rationale and strategies for radiosensitization Semin Radiat Oncol 20 2010 250 257
85. M.E. Mattmann, S.L. Stoops, and C.W. Lindsley Inhibition of Akt with small molecules and biologics: historical perspective and current status of the patent landscape Expert Opin Ther Pat 21 2011 1309 1338
86. J.A. Bonner, P.M. Harari, and J. Giralt Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival Lancet Oncol 11 2010 21 28
87. J.A. Bonner, P.M. Harari, and J. Giralt Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck N Engl J Med 354 2006 567 578 (Pubitemid 43209104)
88. S.H. Zaidi, R.A. Huddart, and K.J. Harrington Novel targeted radiosensitisers in cancer treatment Curr Drug Discov Technol 6 2009 103 134
89. I. Eke, S. Hehlgans, and N. Cordes There's something about ILK Int J Radiat Biol 85 2009 929 936
90. K. Storch, I. Eke, and K. Borgmann Three-dimensional cell growth confers radioresistance by chromatin density modification Cancer Res 70 2010 3925 3934
91. V. Sandfort, I. Eke, and N. Cordes The role of the focal adhesion protein PINCH1 for the radiosensitivity of adhesion and suspension cell cultures PLoS One 5 2010
92. I. Eke, U. Koch, and S. Hehlgans PINCH1 regulates Akt1 activation and enhances radioresistance by inhibiting PP1alpha J Clin Invest 120 2010 2516 2527
93. I. Eke, V. Sandfort, K. Storch, M. Baumann, B. Roper, and N. Cordes Pharmacological inhibition of EGFR tyrosine kinase affects ILK-mediated cellular radiosensitization in vitro Int J Radiat Biol 83 2007 793 802 (Pubitemid 350219106)
94. V. Sandfort, U. Koch, and N. Cordes Cell adhesion-mediated radioresistance revisited Int J Radiat Biol 83 2007 727 732 (Pubitemid 350219112)
95. I. Eke, V. Sandfort, A. Mischkus, M. Baumann, and N. Cordes Antiproliferative effects of EGFR tyrosine kinase inhibition and radiation-induced genotoxic injury are attenuated by adhesion to fibronectin Radiother Oncol 80 2006 178 184 (Pubitemid 44301542)
96. N. Skuli, S. Monferran, and C. Delmas Alphavbeta3/alphavbeta5 integrins-FAK-RhoB: a novel pathway for hypoxia regulation in glioblastoma Cancer Res 69 2009 3308 3316
97. S. Monferran, N. Skuli, and C. Delmas Alphavbeta3 and alphavbeta5 integrins control glioma cell response to ionising radiation through ILK and RhoB Int J Cancer 123 2008 357 364 (Pubitemid 351842020)
98. D. Estrugo, A. Fischer, F. Hess, H. Scherthan, C. Belka, and N. Cordes Ligand bound beta1 integrins inhibit procaspase-8 for mediating cell adhesion-mediated drug and radiation resistance in human leukemia cells PLoS One 2 2007 e269
99. F. Hess, D. Estrugo, A. Fischer, C. Belka, and N. Cordes Integrin-linked kinase interacts with caspase-9 and -8 in an adhesion-dependent manner for promoting radiation-induced apoptosis in human leukemia cells Oncogene 26 2007 1372 1384 (Pubitemid 46340819)
100. H. Chaachouay, P. Ohneseit, M. Toulany, R. Kehlbach, G. Multhoff, and H.P. Rodemann Autophagy contributes to resistance of tumor cells to ionizing radiation Radiother Oncol 99 2011 287 292
101. I. Eke, and N. Cordes Radiobiology goes 3D: how ECM and cell morphology impact on cell survival after irradiation Radiother Oncol 99 2011 271 278
102. I. Eke, and N. Cordes Dual targeting of EGFR and focal adhesion kinase in 3D grown HNSCC cell cultures Radiother Oncol 99 2011 279 286
103. G.C. Barnett, C.E. Coles, and N.G. Burnet No association between SNPs regulating TGF-beta1 secretion and late radiotherapy toxicity to the breast: results from the RAPPER study Radiother Oncol 97 2010 9 14
104. S. Martin, M. Sydenham, and J. Haviland Test of association between variant tgbeta1 alleles and late adverse effects of breast radiotherapy Radiother Oncol 97 2010 15 18
105. M. Niemantsverdriet, E. de Jong, J.A. Langendijk, H.H. Kampinga, and R.P. Coppes Synergistic induction of profibrotic PAI-1 by TGF-beta and radiation depends on p53 Radiother Oncol 97 2010 33 35
106. J. Yarnold, and M.C. Brotons Pathogenetic mechanisms in radiation fibrosis Radiother Oncol 97 2010 149 161
107. F. Rodel, B. Frey, and G. Capalbo Discontinuous induction of X-linked inhibitor of apoptosis in EA.hy.926 endothelial cells is linked to NF-kappaB activation and mediates the anti-inflammatory properties of low-dose ionising-radiation Radiother Oncol 97 2010 346 351
108. C.K. Mueller, and S. Schultze-Mosgau Radiation-induced microenvironments - The molecular basis for free flap complications in the pre-irradiated field? Radiother Oncol 93 2009 581 585
109. J.J. Kruse, B.G. Floot, J.A. te Poele, N.S. Russell, and F.A. Stewart Radiation-induced activation of TGF-beta signaling pathways in relation to vascular damage in mouse kidneys Radiat Res 171 2009 188 197
110. M. Scharpfenecker, J.J. Kruse, D. Sprong, N.S. Russell, P. Ten Dijke, and F.A. Stewart Ionizing radiation shifts the PAI-1/ID-1 balance and activates notch signaling in endothelial cells Int J Radiat Oncol Biol Phys 73 2009 506 513
111. M. Arenas, F. Gil, and M. Gironella Time course of anti-inflammatory effect of low-dose radiotherapy: correlation with TGF-beta(1) expression Radiother Oncol 86 2008 399 406 (Pubitemid 351335448)
112. E.M. Wiegman, M.A. Blaese, H. Loeffler, R.P. Coppes, and H.P. Rodemann TGFbeta-1 dependent fast stimulation of ATM and p53 phosphorylation following exposure to ionizing radiation does not involve TGFbeta-receptor I signalling Radiother Oncol 83 2007 289 295 (Pubitemid 46907986)
113. M. Scharpfenecker, B. Floot, R. Korlaar, N.S. Russell, and F.A. Stewart ALK1 heterozygosity delays development of late normal tissue damage in the irradiated mouse kidney Radiother Oncol 99 2011 349 355
114. J. Kirshner, M.F. Jobling, and M.J. Pajares Inhibition of transforming growth factor-beta1 signaling attenuates ataxia telangiectasia mutated activity in response to genotoxic stress Cancer Res 66 2006 10861 10869 (Pubitemid 44876983)
115. S.M. Huang, K.T. Lu, and Y.C. Wang ATM/ATR and SMAD3 pathways contribute to 3-indole-induced G arrest in cancer cells and xenograft models Anticancer Res 31 2011 203 208
116. D.H. Nguyen, H.A. Oketch-Rabah, and I. Illa-Bochaca Radiation acts on the microenvironment to affect breast carcinogenesis by distinct mechanisms that decrease cancer latency and affect tumor type Cancer Cell 19 2011 640 651
117. P. Lassen, J.G. Eriksen, S. Hamilton-Dutoit, T. Tramm, J. Alsner, and J. Overgaard HPV-associated p16-expression and response to hypoxic modification of radiotherapy in head and neck cancer Radiother Oncol 94 2010 30 35
118. L. Gothard, J. Haviland, and P. Bryson Randomised phase II trial of hyperbaric oxygen therapy in patients with chronic arm lymphoedema after radiotherapy for cancer Radiother Oncol 97 2010 101 107
119. U.G. Sattler, S.S. Meyer, and V. Quennet Glycolytic metabolism and tumour response to fractionated irradiation Radiother Oncol 94 2010 102 109
120. A. Yaromina, H. Thames, and X. Zhou Radiobiological hypoxia, histological parameters of tumour microenvironment and local tumour control after fractionated irradiation Radiother Oncol 96 2010 116 122
121. P.J. Hoskin, A.M. Rojas, M.I. Saunders, S.M. Bentzen, and K.J. Motohashi Carbogen and nicotinamide in locally advanced bladder cancer: early results of a phase-III randomized trial Radiother Oncol 91 2009 120 125
122. B.S. Fox, and S. Sonis TNF and oral mucositis: response to effect of selective inhibitors of inflammation on oral mucositis: preclinical studies Radiother Oncol 92 2009 472 476 Radiother Oncol 2010;94:123; author reply-4
123. H. Hou, J.P. Lariviere, E. Demidenko, D. Gladstone, H. Swartz, and N. Khan Repeated tumor pO(2) measurements by multi-site EPR oximetry as a prognostic marker for enhanced therapeutic efficacy of fractionated radiotherapy Radiother Oncol 91 2009 126 131
124. I. Nawroth, J. Alsner, and M.A. Behlke Intraperitoneal administration of chitosan/DsiRNA nanoparticles targeting TNFalpha prevents radiation-induced fibrosis Radiother Oncol 97 2010 143 148
125. N. Christian, S. Deheneffe, and A. Bol Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Comparison with the hypoxic tracer (14)C-EF3 in animal tumor models Radiother Oncol 97 2010 183 188
126. K. Gulliksrud, B. Mathiesen, K. Galappathi, and E.K. Rofstad Quantitative assessment of hypoxia in melanoma xenografts by dynamic contrast-enhanced magnetic resonance imaging: intradermal versus intramuscular tumors Radiother Oncol 97 2010 233 238
127. F.R. Burlage, H. Faber, H.H. Kampinga, J.A. Langendijk, A. Vissink, and R.P. Coppes Enhanced proliferation of acinar and progenitor cells by prophylactic pilocarpine treatment underlies the observed amelioration of radiation injury to parotid glands Radiother Oncol 90 2009 253 256
128. U.M. Le, D.G. Kaurin, B.R. Sloat, N. Yanasarn, and Z. Cui Localized irradiation of tumors prior to synthetic dsRNA therapy enhanced the resultant anti-tumor activity Radiother Oncol 90 2009 273 279
129. C. Dittfeld, A. Dietrich, and S. Peickert CD133 expression is not selective for tumor-initiating or radioresistant cell populations in the CRC cell line HCT-116 Radiother Oncol 94 2010 375 383
130. K. Ruan, G. Song, and G. Ouyang Role of hypoxia in the hallmarks of human cancer J Cell Biochem 107 2009 1053 1062
131. A. Wouters, B. Pauwels, F. Lardon, and J.B. Vermorken Review: implications of in vitro research on the effect of radiotherapy and chemotherapy under hypoxic conditions Oncologist 12 2007 690 712 (Pubitemid 47036204)
132. S. Rockwell, I.T. Dobrucki, E.Y. Kim, S.T. Marrison, and V.T. Vu Hypoxia and radiation therapy: past history, ongoing research, and future promise Curr Mol Med 9 2009 442 458
133. M. Busk, S. Walenta, and W. Mueller-Klieser Inhibition of tumor lactate oxidation: consequences for the tumor microenvironment Radiother Oncol 99 2011 404 411
134. C.A. Maftei, K. Shi, C. Bayer, S.T. Astner, and P. Vaupel Comparison of (immuno-)fluorescence data with serial [(1)F]Fmiso PET/CT imaging for assessment of chronic and acute hypoxia in head and neck cancers Radiother Oncol 99 2011 412 417
135. K.M. Rouschop, L. Dubois, and M.B. Schaaf Deregulation of cap-dependent mRNA translation increases tumour radiosensitivity through reduction of the hypoxic fraction Radiother Oncol 99 2011 385 391
136. J. Theys, B. Jutten, and R. Habets E-Cadherin loss associated with EMT promotes radioresistance in human tumor cells Radiother Oncol 99 2011 392 397
137. P. Vera, P. Bohn, and A. Edet-Sanson Simultaneous positron emission tomography (PET) assessment of metabolism with (1)F-fluoro-2-deoxy-d-glucose (FDG), proliferation with (1)F-fluoro-thymidine (FLT), and hypoxia with (1)fluoro-misonidazole (F-miso) before and during radiotherapy in patients with non-small-cell lung cancer (NSCLC): a pilot study Radiother Oncol 98 2011 109 116
138. J. Overgaard Hypoxic modification of radiotherapy in squamous cell carcinoma of the head and neck - A systematic review and meta-analysis Radiother Oncol 100 2011 22 32
139. W. Choi, S.W. Lee, and S.H. Park Planning study for available dose of hypoxic tumor volume using fluorine-18-labeled fluoromisonidazole positron emission tomography for treatment of the head and neck cancer Radiother Oncol 97 2010 176 182
140. E.G. Troost, D.A. Schinagl, J. Bussink, W.J. Oyen, and J.H. Kaanders Clinical evidence on PET-CT for radiation therapy planning in head and neck tumours Radiother Oncol 96 2010 328 334
141. D. Thorwarth, and M. Alber Implementation of hypoxia imaging into treatment planning and delivery Radiother Oncol 97 2010 172 175
142. W.R. Wilson, and M.P. Hay Targeting hypoxia in cancer therapy Nat Rev Cancer 11 2011 393 410
143. N. Christian, J.A. Lee, A. Bol, M. De Bast, B. Jordan, and V. Gregoire The limitation of PET imaging for biological adaptive-IMRT assessed in animal models Radiother Oncol 91 2009 101 106
144. A.L. Grosu, and W.A. Weber PET for radiation treatment planning of brain tumours Radiother Oncol 96 2010 325 327
145. D. De Ruysscher, and C.M. Kirsch PET scans in radiotherapy planning of lung cancer Radiother Oncol 96 2010 335 338
146. F.P. D'Andrea, A. Safwat, M. Kassem, L. Gautier, J. Overgaard, and M.R. Horsman Cancer stem cell overexpression of nicotinamide N-methyltransferase enhances cellular radiation resistance Radiother Oncol 99 2011 373 378
147. S.M. Harding, C. Coackley, and R.G. Bristow ATM-dependent phosphorylation of 53BP1 in response to genomic stress in oxic and hypoxic cells Radiother Oncol 99 2011 307 312
148. L.S. Mortensen, M. Busk, and M. Nordsmark Accessing radiation response using hypoxia PET imaging and oxygen sensitive electrodes: a preclinical study Radiother Oncol 99 2011 418 423
149. M.M. Nijkamp, P.N. Span, I.J. Hoogsteen, A.J. van der Kogel, J.H. Kaanders, and J. Bussink Expression of E-cadherin and vimentin correlates with metastasis formation in head and neck squamous cell carcinoma patients Radiother Oncol 99 2011 344 348
150. S. Stangl, G. Themelis, and L. Friedrich Detection of irradiation-induced, membrane heat shock protein 70 (Hsp70) in mouse tumors using Hsp70 Fab fragment Radiother Oncol 99 2011 313 316
151. G.O. Ahn, and J.M. Brown Matrix metalloproteinase-9 is required for tumor vasculogenesis but not for angiogenesis: role of bone marrow-derived myelomonocytic cells Cancer Cell 13 2008 193 205 (Pubitemid 351318369)
152. J.S. Greenberger, and M. Epperly Bone marrow-derived stem cells and radiation response Semin Radiat Oncol 19 2009 133 139
153. R.P. Coppes, A. van der Goot, and I.M. Lombaert Stem cell therapy to reduce radiation-induced normal tissue damage Semin Radiat Oncol 19 2009 112 121
154. I.M. Lombaert, P.K. Wierenga, T. Kok, H.H. Kampinga, G. deHaan, and R.P. Coppes Mobilization of bone marrow stem cells by granulocyte colony-stimulating factor ameliorates radiation-induced damage to salivary glands Clin Cancer Res 12 2006 1804 1812
155. M. Baumann, M. Krause, and R. Hill Exploring the role of cancer stem cells in radioresistance Nat Rev Cancer 8 2008 545 554 (Pubitemid 351881850)
156. G.H. Nguyen, M.M. Murph, and J.Y. Chang Cancer stem cell radioresistance and enrichment: where frontline radiation therapy may fail in lung and esophageal cancers Cancers (Basel) 3 2011 1232 1252
157. H.S. Hsu, P.I. Huang, and Y.L. Chang Cucurbitacin I inhibits tumorigenic ability and enhances radiochemosensitivity in nonsmall cell lung cancer-derived CD133-positive cells Cancer 117 2011 2970 2985
158. K.H. Chen, C.C. Hsu, and W.S. Song Celecoxib enhances radiosensitivity in medulloblastoma-derived CD133-positive cells Childs Nerv Syst 26 2010 1605 1612
159. J.J. Short, and D.T. Curiel Oncolytic adenoviruses targeted to cancer stem cells Mol Cancer Ther 8 2009 2096 2102
160. M. Diehn, R.W. Cho, and N.A. Lobo Association of reactive oxygen species levels and radioresistance in cancer stem cells Nature 458 2009 780 783
161. X. Zhang, R. Komaki, L. Wang, B. Fang, and J.Y. Chang Treatment of radioresistant stem-like esophageal cancer cells by an apoptotic gene-armed, telomerase-specific oncolytic adenovirus Clin Cancer Res 14 2008 2813 2823
162. J. Mihatsch, M. Toulany, and P.M. Bareiss Selection of radioresistant tumor cells and presence of ALDH1 activity in vitro Radiother Oncol 99 2011 300 306
163. L.S. Nanduri, M. Maimets, S.A. Pringle, M. van der Zwaag, R.P. van Os, and R.P. Coppes Regeneration of irradiated salivary glands with stem cell marker expressing cells Radiother Oncol 99 2011 367 372
164. M.R. Stratton Exploring the genomes of cancer cells: progress and promise Science 331 2011 1553 1558
165. D.T. Miyamoto, and J.R. Harris Molecular predictors of local tumor control in early-stage breast cancer Semin Radiat Oncol 21 2011 35 42
166. G. Bronte, M. Terrasi, and S. Rizzo EGFR genomic alterations in cancer: prognostic and predictive values Front Biosci (Elite Ed) 3 2011 879 887
167. S. Rizzo, G. Bronte, and D. Fanale Prognostic vs predictive molecular biomarkers in colorectal cancer: is KRAS and BRAF wild type status required for anti-EGFR therapy? Cancer Treat Rev 36 2010 S56 S61
168. L. Zitvogel, O. Kepp, and L. Aymeric Integration of host-related signatures with cancer cell-derived predictors for the optimal management of anticancer chemotherapy Cancer Res 70 2010 9538 9543
169. C.N. Andreassen Searching for genetic determinants of normal tissue radiosensitivity - Are we on the right track? Radiother Oncol 97 2010 1 8
170. C. West, and B.S. Rosenstein Establishment of a radiogenomics consortium Radiother Oncol 94 2010 117 118
171. N. Pratesi, M. Mangoni, and I. Mancini Association between single nucleotide polymorphisms in the XRCC1 and RAD51 genes and clinical radiosensitivity in head and neck cancer Radiother Oncol 99 2011 356 361
172. C.N. Andreassen, and J. Alsner Genetic variants and normal tissue toxicity after radiotherapy: a systematic review Radiother Oncol 92 2009 299 309
173. S.H. Settle, and E.P. Sulman Tumor profiling: development of prognostic and predictive factors to guide brain tumor treatment Curr Oncol Rep 13 2011 26 36
174. P.C. Sacco, P. Maione, and A. Rossi Combination of radiotherapy and targeted therapies in the treatment of locally advanced non-small cell lung cancer Target Oncol 6 2011 171 180
175. W. Wick, M. Weller, M. Weiler, T. Batchelor, A.W. Yung, and M. Platten Pathway inhibition: emerging molecular targets for treating glioblastoma Neuro Oncol 13 2011 566 579
176. A. Broggini-Tenzer, V. Vuong, and M. Pruschy Metabolism of tumors under treatment: mapping of metabolites with quantitative bioluminescence Radiother Oncol 99 2011 398 403
177. L. Dubois, S. Peeters, and N.G. Lieuwes Specific inhibition of carbonic anhydrase IX activity enhances the in vivo therapeutic effect of tumor irradiation Radiother Oncol 99 2011 424 431
178. T. van den Beucken, M.G. Magagnin, and B. Jutten Translational control is a major contributor to hypoxia induced gene expression Radiother Oncol 99 2011 379 384